Metrics In Balance NV (XPAR:MLMIB) EBITDA Margin %: 83.33% (As of Dec. 2024)


XPAR:MLMIB Metrics In Balance NV XPAR:MLMIB
4 GF Score
Price €0.03
! 3 Warning Signs
View Full Analysis

What is Metrics In Balance NV EBITDA Margin %?

Metrics In Balance NV XPAR:MLMIB 4 EBITDA Margin % is 83.33% as of Dec. 2024. GuruFocus rates XPAR:MLMIB with a GF Score™ of 4/100. The stock has 3 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Metrics In Balance NV's EBITDA for the six months ended in Dec. 2024 was €0.03 Mil. Metrics In Balance NV's Revenue for the six months ended in Dec. 2024 was €0.03 Mil. Therefore, Metrics In Balance NV's EBITDA margin for the quarter that ended in Dec. 2024 was 83.33%.

Metrics In Balance NV  (XPAR:MLMIB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Metrics In Balance NV EBITDA Margin % Related Terms

Metrics In Balance NV EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Metrics In Balance NV's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metrics In Balance NV EBITDA Margin % Chart

Metrics In Balance NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial 90.24 47.27 0.00 0.00 83.33

Metrics In Balance NV Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin % Get a 7-Day Free Trial 90.24 47.27 0.00 0.00 83.33

XPAR:MLMIB vs MCK, COR, CAH: EBITDA Margin % Comparison

For the Medical Distribution subindustry, Metrics In Balance NV's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metrics In Balance NV EBITDA Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Metrics In Balance NV's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Metrics In Balance NV's EBITDA Margin % falls into.


XPAR:MLMIB
4GF Score
Metrics In Balance NV XPAR:MLMIB
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metrics In Balance NV EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Metrics In Balance NV's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=0.025/0.03
=83.33 %

Metrics In Balance NV's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=0.025/0.03
=83.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 83.33% mean?
Metrics In Balance NV (XPAR:MLMIB) has a EBITDA Margin % of 83.33% as of Dec. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metrics In Balance NV and its competitors.
Is Metrics In Balance NV's EBITDA Margin % too high?
Metrics In Balance NV's current EBITDA Margin % is 83.33%. The Medical Distribution industry median EBITDA Margin % is 4.20. Metrics In Balance NV's value of 83.33% is 1884% above this industry median. Overall, Metrics In Balance NV has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metrics In Balance NV's EBITDA Margin % compare to MCK and COR?
Metrics In Balance NV's EBITDA Margin % of 83.33% can be compared against companies in the Medical Distribution industry. The industry median EBITDA Margin % is 4.20. Metrics In Balance NV's value of 83.33% is 1884% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.20, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metrics In Balance NV's current EBITDA Margin % of 83.33% is 1884% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Metrics In Balance NV and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metrics In Balance NV's current EBITDA Margin % is 83.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics In Balance NV stock overvalued right now?
Metrics In Balance NV (XPAR:MLMIB) has a current EBITDA Margin % of 83.33%. The current EBITDA Margin % is 83.33% and 1884% above the Medical Distribution industry median of 4.20. Metrics In Balance NV's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Metrics In Balance NV (XPAR:MLMIB), the current EBITDA Margin % is 83.33% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metrics In Balance NV Business Description

Address Regenboog 1, Melle, BEL, 9090
Metrics In Balance NV is engaged in the sale of medical devices for the measurement, diagnosis, and resolution of disorders related to dental occlusion malfunction.
4GF Score

Get the complete analysis for XPAR:MLMIB

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price